H.R. 7693 Introduced Health

Leo’s Law

To mitigate the effects of the COVID-19 pandemic on incentives under the Federal Food, Drug, and Cosmetic Act for the development of orphan drugs, and for other purposes.

  1. Introduced
  2. Committee
  3. Passed House
  4. Passed Senate
  5. To President
  6. Became law
Sponsor Rep. Gottheimer, Josh [D-NJ-5] Introduced February 25, 2026 Cosponsors 1 (1 R) Latest action February 25, 2026

Summary

Leo's Law
This bill extends by 180 days the relevant periods of market exclusivity for drugs for rare diseases or conditions (i.e., orphan drugs) for which applications were submitted during the COVID-19 emergency period.

Summary by the Congressional Research Service, Library of Congress.

Congress.gov

Actions

  1. Feb 25, 2026 Referred to the House Committee on Energy and Commerce.
  2. Feb 25, 2026 Introduced in House

Congressional and federal records come from official public sources: the House Clerk, the U.S. Senate, GovInfo and the Library of Congress (bill status), the Federal Register, and the congress-legislators project. They are copied on a schedule and may lag the official record by a few hours; the official sources govern. News and coverage counts are drawn from the 4Conservative index and reflect what the press published, not 4Conservative's views. Nothing here is an endorsement of any candidate, party or position. Terms of use.